Objective-To study opportunistic screening in primary care, in such a way that would include teenage women. Setting-Screening for chlamydia infection was oVered opportunistically in eight general practices in Edinburgh to women aged < 35 years attending for cervical smear, and women aged < 20 years attending for contraception. The numbers of women eligible to be oVered screening were 901 in the cervical smear group, and 595 in the contraception group. Results-EVective screening rate (oVered test, consented, and urine sample returned) was 30% for the cervical smear group compared with 23% for the contraception group. Among those tested, chlamydia prevalence was strongly associated with young age, ranging from 11.8% in those <18 years, to 0% in those >25 years. Number of sexual partners in past year did not improve prediction of infection. Conclusion-These findings raise concerns regarding the feasibility of opportunistic screening in general practice, particularly for those with highest prevalence of chlamydia-teenage women. (J Med Screen 2000;7:175-176) 
Chlamydia is the most common sexually transmitted infection in developed countries. 1 In women, it can lead to pelvic inflammatory disease (PID), ectopic pregnancy, and infertility, 2 but is usually asymptomatic. A randomised controlled trial in the USA has shown that selective screening for chlamydia reduces subsequent incidence of PID. 3 Published reports have shown higher prevalence of chlamydia in women < 25 years of age, particularly those <20 years (11%), and among those reporting more than one sexual partner in the previous year (5%). 4 The approach taken in the UK is to recommend that chlamydia screening be oVered opportunistically to sexually active women aged < 25 years, in particular teenagers. 5 Although chlamydia screening can be oVered alongside cervical screening, most women in the UK do not receive cervical screening until 20 years of age. A feasibility study was therefore required of opportunistic screening in primary care, in such a way that would include teenage women.
Participants and methods
Recruitment took place during routine surgeries in eight general practices in Edinburgh over a period of 10 months (three practices) or three months (five practices). Practice meetings were attended, recruitment materials were kept up to date in a separate tray in every consulting room, and reminders about the study were sent monthly to all participating staV. Women aged < 35 years attending for cervical screening, and women aged < 20 years attending for contraception or pregnancy test, and not already recruited into the study, were invited to participate by practice nurses and general practitioners. Informed consent was obtained. The total number of potential recruits was ascertained by checking records of cervical smears, and medical notes of women aged < 20 years, for each practice for the relevant period. Urine samples were tested by Roche polymerase chain reaction (Roche Diagnostics Ltd, Lewes, UK) or Abbott ligase chain reaction (Abbot Diagnostics Division, Maidenhead UK) with confirmatory testing for positive results. Percentages were compared using the 2 test, and the association of chlamydia prevalence with risk factors was tested by binary logistic regression, with study group included in the model.
Results
For the two study groups, table 1 shows the numbers of women eligible to be oVered screening in the recruitment period, eVective screening rate (the percentage actually tested), and of those tested, the percentage positive for chlamydia. In total, 36% of eligible women were oVered and gave signed consent to screening. Examination of medical records suggested that nonrecruitment was mainly because the test had not been oVered, rather than that women had declined to participate, and staV suggested lack of time was the main problem with recruitment. Overall, 25% of women recruited did not subsequently return a urine specimen (contraception group 31% v cervical smear group 20%; 2 1df = 6.9 p = 0.008). So the eVective screening rate in women attending for contraception was 23%.
Age was strongly associated with chlamydia prevalence, ranging from 11.8% in those aged < 18 years to 0% in those aged >26. The odds of chlamydia decreased by 30% per year increase in age (p = 0.008, odds ratio (OR) 0.70, 95% confidence interval (CI) 0.54-0.91). Overall, 19% of women reported more than one sex partner in the previous year. This risk factor is strongly associated with recruitment group (contraception 26% v cervical smear 16%; 2 1df = 8.3 p = 0.004), and within the cervical smear group with younger age (<25 years 28% v 26 or over 8%; 2 1df = 21.4 p < 0.001). Considered as the only risk factor, "more than one partner" was associated with chlamydia (8.1% v 2.5%, p = 0.027, OR 3.4, 95% CI 1.1-10.1), but once age was entered in the model it was no longer predictive (p = 0.21).
Discussion
The high prevalence of chlamydia infection in women attending for contraception, especially those aged < 18 years, demonstrates the importance of targeting chlamydia screening at sexually active teenage women. This study is the first to report findings for opportunistic screening of this group in general practice. In their study, Grun et al included 63 women aged 18 and 19 who responded to a written invitation to a "well young woman check", 4 but they did not attempt opportunistic screening during routine consultations. The disappointingly low eVective testing rate for this group in our study cautions that opportunistic screening in general practice may not be an eYcient way to control chlamydia infection in teenage women.
Practices in this research study received considerable input in terms of visits and reminders to recruit. If opportunistic screening is introduced to general practice, the eVective screening rate for teenage women is unlikely to be any higher than that presented here (23%), unless a structured incentive system is introduced, together with a campaign to raise public and professional awareness. Furthermore, if practices do not have access to chlamydia testing of urine samples then the unavailability of this non-invasive test will reduce even further the likelihood these teenage women will be oVered screening.
In our study, once recruitment group and age were taken into account, the reporting of "two or more sex partners in past year" did not significantly improve prediction of infection. Among those > 25 years, for whom selective screening by this factor has been recommended, 5 there were no cases of chlamydia. These findings are very similar to those reported by Grun et al, where a selective strategy for women > 25 years, based on number of partners in past year, would have meant 553 women questioned to identify an additional 106 women to be screened, to diagnose only three cases. 4 The marginal gain in case detection should be considered in the light of the intimate nature of the information required. In cervical screening, which initially involved asking about number of sexual partners, women with a positive result associated it with promiscuity and consequently felt stigmatised, 6 and the potential for similar stigmatisation through chlamydia screening has been highlighted. 7 A selective strategy on the basis of sexual history might have adverse eVects on screening uptake in both women over 25 and younger women.
Evidence is required about the prevalence of chlamydia among sexually active teenage women who have not attended for contraception and therefore not been screened, and also among those attending but not tested. However, the implication of the present study is that among teenage women attending for contraception, 10 in every 100 have chlamydia, and only two to three of them will have the infection detected by opportunistic screening, leaving seven at risk of adverse sequelae and of passing on infection. This is of concern and highlights the need for concerted action to reach these women. M Santer, P Warner, and S Wyke were all involved in the study design, data analysis, and interpretation. S Sutherland was responsible for laboratory analysis of the samples and contributed to revising the article. Elaine Kacser collected data and Craig Patrizio carried out the tests. We are very grateful to the staV and patients of all the practices who took part in the study.
